Related references
Note: Only part of the references are listed.Limitations of the Murine Nose in the Development of Nonviral Airway Gene Transfer
Uta Griesenbach et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
David A. Stoltz et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
Uta Griesenbach et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets
Xingshen Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Production of CFTR-null and CFTR-ΔF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer
Christopher S. Rogers et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes
Lee A. Davies et al.
MOLECULAR THERAPY (2008)
Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA
Xuguang Chen et al.
MOLECULAR THERAPY (2008)
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C. Hyde et al.
NATURE BIOTECHNOLOGY (2008)
Optimizing aerosol gene delivery and expression in the ovine lung
Gerry McLachlan et al.
MOLECULAR THERAPY (2007)
Human-specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways
Heather Davidson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Gene transfer of CFTR to airway epithelia:: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR
SL Farmen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application
C Rudolph et al.
JOURNAL OF GENE MEDICINE (2005)
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
MW Konstan et al.
HUMAN GENE THERAPY (2004)
Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments
M Emerson et al.
MOLECULAR THERAPY (2003)
Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study
EF McKone et al.
LANCET (2003)
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo
AG Ziady et al.
MOLECULAR THERAPY (2003)
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
AG Ziady et al.
MOLECULAR THERAPY (2003)
Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways
AC Rose et al.
GENE THERAPY (2002)
Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector
S Cunningham et al.
JOURNAL OF GENE MEDICINE (2002)
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter
DR Gill et al.
GENE THERAPY (2001)
A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis
FE Ruiz et al.
HUMAN GENE THERAPY (2001)
Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization
CL Densmore et al.
MOLECULAR THERAPY (2000)
Share Paper
